GNCA vs. GNCAQ, VECT, GRTS, NTGN, BLUE, ZIOP, AGEN, AMGN, GILD, and MRNA
Should you be buying Genocea Biosciences stock or one of its competitors? The main competitors of Genocea Biosciences include Genocea Biosciences (GNCAQ), VectivBio (VECT), Gritstone bio (GRTS), Neon Therapeutics (NTGN), bluebird bio (BLUE), ZIOPHARM Oncology (ZIOP), Agenus (AGEN), Amgen (AMGN), Gilead Sciences (GILD), and Moderna (MRNA). These companies are all part of the "medical" sector.
Genocea Biosciences (NASDAQ:GNCA) and Genocea Biosciences (NASDAQ:GNCAQ) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, community ranking, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.
Genocea Biosciences has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, Genocea Biosciences has a beta of 2.68, meaning that its stock price is 168% more volatile than the S&P 500.
In the previous week, Genocea Biosciences had 1 more articles in the media than Genocea Biosciences. MarketBeat recorded 1 mentions for Genocea Biosciences and 0 mentions for Genocea Biosciences. Genocea Biosciences' average media sentiment score of 0.00 equaled Genocea Biosciences'average media sentiment score.
0.6% of Genocea Biosciences shares are held by institutional investors. 1.6% of Genocea Biosciences shares are held by company insiders. Comparatively, 1.6% of Genocea Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Genocea Biosciences received 388 more outperform votes than Genocea Biosciences when rated by MarketBeat users.
Genocea Biosciences' return on equity of 0.00% beat Genocea Biosciences' return on equity.
Summary
Genocea Biosciences beats Genocea Biosciences on 4 of the 7 factors compared between the two stocks.
Get Genocea Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for GNCA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GNCA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genocea Biosciences Competitors List
Related Companies and Tools
